Select region

Subscribe to our news feed


A question?

Life science solutions keeps Ingrid from losing her sight

If it wasn’t for the life science industry and its ability to discover and bring forward new drugs, Getinge employee Göran Carlsson’s mother would’ve been fully blind: “Seeing the proof up so closely, of what our customers can accomplish with the help of our solutions is simply amazing.”

Getinge partnership in India pioneers AI in the ICU

Getinge’s cooperation with the Indian Institute of Technology (IIT) in Mumbai is an example of how the company strengthens its research in areas with growing importance. Current focus for the partnership is a system using Artficial Intelligence (AI) to help understaffed Intensive Care Units (ICUs) detect which patients that are in most need of urgent care.

Resolutions at Getinge’s Annual General Meeting 26 April 2023

Getinge AB (publ)’s Annual General Meeting (“AGM”) was held on 26 April 2023 in Kongresshallen, Hotel Tylösand, Halmstad, Sweden. At the AGM, the following was resolved.

Getinge Interim Report January-March 2023: Increased sales, strengthened earnings and PMA approval for iCast™ in the US

“The order intake and net sales increased organically by 2.9% and 7.5%, respectively, during the quarter”, says Mattias Perjos, President & CEO. “The higher sales volumes, price increases and positive currency effects contributed to both gross and operating profit strengthening, despite higher costs for purchases of both input goods and services as well as salaries.”

Getinge continues partnership with Pratham Sweden

Together with other leading Swedish industries, Getinge has prolonged its partnership with the Swedish Industry for Quality Education in India as part of Pratham Sweden, supporting Pratham’s important work to ensure learning and growth of children in India. 

Getinge part of EU project to develop artificial placenta for neonatales

Despite big medical progress in the past 50 years, a high number of neonatal deaths occur every year. A consortium with members from academia and industry, including Getinge, have now received funding to develop  an artificial placenta to keep supporting lung and kidney function development after birth – in an attempt to save the lives of more premature newborns.

Press Contacts

Jeanette Hedén Carlsson

Jeanette Hedén Carlsson

EVP Brand & Communication
Phone: +46 10 335 1003

Anna Appelqvist

Vice President Corporate Communications
Phone: +46 10 335 5906

Press and media Getinge

Prefer to contact us online

Click below to fill in the appropriate form. We will be in touch shortly.

Are you looking for

Getinge Hybrid OR

Image Gallery

Diverse picture format made available for press article purpose 

Man and woman looking a something together

About us

All you need to know about Getinge a one glance


Urgent Medical Device Correction

Voluntary Urgent Medical Device Field Correction for the CARDIOSAVE intra-aortic balloon pump (IABP)


Don't miss anything

Click on the icons and follow us!